{"id":3838,"count":1,"description":"Genital warts are caused by human papillomavirus (HPV) types 6 and 11 in over 90% of cases \u2014 non-cancerous but cosmetically and psychologically distressing, with high transmission rate to partners. Treatment options include topical immune-response modifiers (imiquimod), cytotoxic agents (podophyllotoxin), and clinic-based ablation (cryotherapy, electrocautery, laser, surgical excision).\n\n<strong>Op voorraad optie.<\/strong> Imiquimod 5% cream is the most-used topical immunotherapy for external genital warts. Apply to wart areas at bedtime three times weekly (alternate nights) for up to 16 weeks; wash off in the morning (6\u201310 hours after application). Stocked as <a href=\"https:\/\/medsbase.com\/nl\/imiquad-cream\/\">Imiquad Cr\u00e8me<\/a>. Side-effects: local erythema, erosion, itching, burning \u2014 these are part of the immune response and signal effective treatment. Recurrence is possible; partners should be examined and treated as needed. Podophyllotoxin solution (an alternative cytotoxic agent for self-application) is not currently in our routine stock.\n\n<strong>Hoe te gebruiken.<\/strong> External anogenital warts in non-pregnant adults \u2192 imiquimod 5% cream three nights per week, up to 16 weeks. Pregnancy \u2192 cryotherapy or trichloroacetic acid in clinic; do not use imiquimod or podophyllotoxin in pregnancy. Vaginal, cervical, anal, or urethral warts \u2192 specialist gynaecology \/ colorectal \/ urology referral for clinic-based treatment. Large or refractory lesions \u2192 ablative treatment \u00b1 biopsy.\n\n<strong>Belangrijk.<\/strong> Genital warts diagnosis warrants STI screening (HIV, syphilis, chlamydia, gonorrhoea, hepatitis B\/C). HPV vaccination (Gardasil 9, available through public health programmes in many countries) reduces but does not eliminate recurrence risk and is not effective treatment for established warts. Cervical screening remains essential for women \u2014 high-risk HPV types (16, 18, others) cause cervical cancer; the wart-causing low-risk types (6, 11) do not. Persistent or atypical lesions warrant biopsy to exclude pre-malignant change. All MedsBase products ship from <strong>WHO-GMP gecertificeerde fabrikanten<\/strong> met discrete verpakking en vallen onder onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.","link":"https:\/\/medsbase.com\/nl\/genital-warts-treatment\/","name":"Behandeling van genitale wratten","slug":"genital-warts-treatment","taxonomy":"product_cat","parent":3337,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat\/3838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat\/3337"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product?product_cat=3838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}